Levofloxacin Market Excessive Growth Opportunities Estimated to Be Experienced 2020-2025 | International Company's - Lupin Pharma, Alna Biotech Private, Bestochem, Glenmark Pharma, Pax Healthcare

Overview of Global Levofloxacin Market:

This report provides in-depth study of "Global Levofloxacin Market 2020" using SWOT analysis i.e. Strength, Weakness, Opportunities, and Threat to the organization. The Levofloxacin Market report also provides an in-depth survey of key players in the market organization.

The major key factor drives the growth of the Global Levofloxacin Market is increase in the cases of bacterial infectious diseases. According to the WHO (World Health Organization), pneumonia accounts for 15% of all deaths of children under 5 years old, killing 808694 children in 2017. High burden of antibiotic-resistant infections and emergence of multi-drug resistant pathogens have been augmenting the market.

Available Exclusive Sample Copy of this Report @ https://www.businessindustryreports.com/sample-request/262293 .

In terms of the regional analysis, North America is leading owing to the presence of major market players. Furthermore, factors such as increasing prevalence of chronic diseases, treatment cost, technological advancements, and product launches are expected to drive the regional growth. APAC is expected to show exponential growth throughout the forecast period. This growth can be attributed to increase in prevalence of pneumococcal disease, unmet patient needs, increased cases of antimicrobial resistance, and rise in disorders leading to weakened immune system thereby contributing to the growth of the region.

Through the statistical analysis, the report depicts the international Levofloxacin Market including capacity, production, production value, cost/profit, supply/demand and global import/export. The total market is further divided by company, by country, and by application/type for the competitive landscape analysis. The report then estimates 2020-2025 market development trends of Levofloxacin industry. Analysis of upstream raw materials, downstream demand, and current market dynamics is also carried out.

Global Key Vendors:

1 Alna Biotech Private

2 Allenge India Pharma

3 Bestochem

4 Divine Savior Healthcare

5 Glenmark Pharmaceuticals

6 Pax Healthcare

7 Aden Healthcare

8 Lupin Pharmaceuticals

9 Dr. Reddys Laboratories

10 Zydus Cadila and More.......................

Purchase this report online with 90 Pages, List of Tables & Figures and in-depth Table of Contents on "Global Levofloxacin Market Report 2020" @ https://www.businessindustryreports.com/buy-now/262293/single .

Product Type Segmentation

1 250 mg

2 500 mg

3 750 mg

Industry Segmentation

1 Pneumonia

2 Skin Infection

3 Kidney Infection

4 Bladder Infection

Latest Pharmaceutical Industry News:

Lupin Pharmaceuticals (March 27, 2020) - Lupin and Mylan announce Positive European Medicines Agency opinion recommending Approval of Nepexto, Biosimilar Etanercept - Lupin Limited and Mylan N.V. today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the approval of Nepexto, a biosimilar to Enbrel (etanercept), for all indications of the reference product including rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, axial spondyloarthritis (including ankylosing spondylitis and non-radiographic axial spondyloarthritis), plaque psoriasis and paediatric plaque psoriasis.

The positive CHMP opinion is based on a biosimilarity assessment which included preclinical and clinical studies demonstrating bioequivalence to the reference product. In addition, a phase 3 clinical studyi in patients with moderate-to-severe active rheumatoid arthritis confirmed equivalence of Nepexto to the reference product in terms of efficacy, safety and immunogenicity.

The CHMP positive opinion will now be considered by the European Commission (EC). Once approved, the EC will grant a centralized marketing authorization for member countries of the EU. The decision on the EC's approval is expected in May 2020.

Vinita Gupta, CEO, Lupin Limited said, "Biosimilars like Nepexto will play a critical role in expanding access to patients in Europe, providing an effective treatment for multiple therapies including rheumatoid arthritis. We are extremely pleased with the positive CHMP opinion on our application. This milestone brings us one step closer to bringing an affordable biosimilar to etanercept to the European market through our partner Mylan. Once approved by the European Commission, Nepexto will be our first biosimilar to receive regulatory approval in Europe. Building on this progress, we continue to focus on advancing our biosimilar pipeline."

Mylan President, Rajiv Malik commented, "We are pleased with the positive CHMP opinion for Nepexto, biosimilar etanercept. This recommendation validates the strong scientific program supporting this important treatment, which is one of 20 biosimilar products in our broad and diverse biosimilars portfolio, and our shared commitment with Lupin to help increase access to more affordable biologics treatments, such as etanercept, in Europe and many other regions around the world."

Grab Your Report at an Impressive Discount @ https://www.businessindustryreports.com/check-discount/262293 .

Major Points in Table of Contents:

Global Levofloxacin Market Report 2020

1 Levofloxacin Product Definition

2 Global Levofloxacin Market Manufacturer Share and Market Overview

2.1 Global Manufacturer Levofloxacin Shipments

2.2 Global Manufacturer Levofloxacin Business Revenue

2.3 Global Levofloxacin Market Overview

3 Manufacturer Levofloxacin Business Introduction

3.1 Alna Biotech Private Levofloxacin Business Introduction

3.2 Allenge India Pharma Levofloxacin Business Introduction

3.3 Bestochem Levofloxacin Business Introduction

3.4 Divine Savior Healthcare Levofloxacin Business Introduction

3.5 Glenmark Pharmaceuticals Levofloxacin Business Introduction

3.6 Pax Healthcare Levofloxacin Business Introduction

About us

BusinessindustryReports.com is a digital database of comprehensive market reports for global industries. As a market research company, we take pride in equipping our clients with insights and data that holds the power to truly make a difference to their business. Our mission is singular and well-defined - we want to help our clients envisage their business environment so that they are able to make informed, strategic and therefore successful decisions for themselves.

Media Contact

Business Industry Reports

Pune - India

sales@businessindustryreports.com

+19376349940

This release was published on openPR.